118 results on '"Olefir, Yu."'
Search Results
2. Analysis of Antitumor Activity of the Liposomal Photosensitizer Lipophthalocyan
3. Validation of a Method for Assay of Excipients in Liposomal Medicinal Formulations of the Photosensitizer Lipophthalocyan
4. Pharmacopoeial Quality Requirements for Medicinal Products
5. Validation of Methods and Procedures in Pharmacopoeial Monographs in the Framework of a Drug Standardization Program
6. Standardization of Drug Substances According to the Purity Section
7. Synthesis and some Pharmacological Properties of an Immunoactive Lysine-Containing Tetrapeptide
8. Plant Juices and Related Medicinal Preparations: Issues of Standardization and Quality Control
9. Development of a Sample-Preparation Procedure for Quantitative Determination of Lead in Sugars by Inductively Coupled-Plasma—Atomic-Emission Spectrometry (ICP-AES)
10. Validation of a Quantitative Determination Method for Ormustine in a Lyophilized Dosage Form
11. The Sixth Edition of the WHO laboratory manual for the examination and processing of human semen: is everything new a well-forgotten old?
12. What should urologist know about sperm DNA fragmentation
13. Interchangeability Problems of Drugs with Narrow Therapeutic Indices
14. Interchangeability Criteria for Levofloxacin-Based Medicinal Products in the Russian Federation
15. Optimization of Drug Administration Dosage Regimen Considering Chronorhythms and Desynchronosis of Gastrointestinal-Tract Organs
16. Toxic and Immunomodulatory Properties of an Iron(II) Coordination Complex of Isoleucyltryptophan Dipeptide
17. Influence of Human Biorhythms on the Blood Glucose Level and the Efficacy of Hypoglycemic Drugs (Review)
18. Planning Bioequivalence Studies of Drugs with Narrow Therapeutic Indices
19. Selection of Standardization Parameters and Development of Quality Control Methods for Isoleucyl-Tryptophan Dipeptide Coordination Complex with Iron(II) (Timofer)
20. Vaccine interchangeability: problems and prospects
21. Comparison of the World Pharmacopoeias’ Requirements for the Quality of Cell Lines
22. Whole-Genome Sequencing and Phylogenetic Analysis of Francisella tularensis Vaccine Strain 15 NIIEG
23. Safety assessment of biological raw materials in the system of medicines quality assurance
24. An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare
25. Quality Control of Ethyl Alcohol Used as a Medicinal Product
26. The Use of Short Tandem Repeat Analysis for Cell Line Authentication
27. Identification and Evaluation of Safety Signals of Drugs Currently under Development Using a Limited Data Set
28. The Mechanism of Action of Follistatin-like Protein-1 (FSTL-1)
29. International Drug Safety Monitoring
30. Assessment of the Effectiveness of Implementation of Information Systems for Medicines Evaluation
31. Drug Safety for Children — International Monitoring Data for 50 Years
32. DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies
33. Current Challenges of Preventive Vaccination Against Rabies
34. Post-approval Variations to Dossiers for Vaccines: Analysis of Regulatory and Methodological Approaches Used in the Russian Federation and Abroad
35. STANDARDIZATION OF DESCRIPTION OF MEDICAL PRODUCTS
36. International Practice of Storing Human Cell Lines Intended for Clinical Use
37. Assessment of Pharmacovigilance Reporting in Russia
38. ASSESSMENT OF ACTUAL TERMS OF REGISTRATION EXAMINATION OF MEDICINES FOR 2011-2018
39. EXPERT EVALUATION OF PRECLINICAL STUDIES OF PRIMARY AND SECONDARY PHARMACODYNAMICS OF MEDICINES
40. ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
41. THE EVALUATION OF RISKS AT APPLICATION OF CARDIO-VASCULAR MEDICATIONS
42. Use of Flow Cytometry for Quality Evaluation of Biomedical Cell Products
43. Rivaroxaban: comparative analysis of information on adverse reactions from Russian and international databases
44. Personalized medicine in internal medicine
45. The Study of Protective Properties of Vaccines against Virulent Strains of the Virus Tick-Borne Encephalitis Three Genotypes: European, Far Eastern and Siberian (Experimental Research)
46. METHODOLOGICAL APPROACHES TO EXPERT EVALUATION OF PRECLINICAL AND CLINICAL TRIALS OF HUMAN IMMUNOGLOBULIN PRODUCTS
47. The Use of a Heterologous Anti-Rabies Immunoglobulin for Specific Prevention of Human Rabies
48. Outlook for the Use of Focused Shock Waves and Pulsed Electric Fields in the Complex Treatment of Malignant Neoplasms
49. Curative Effect of General Geomagnetictherapy
50. The problem of interchangeability of antiepileptic drugs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.